Growth Metrics

Repligen (RGEN) Current Deferred Revenue (2016 - 2025)

Repligen (RGEN) has disclosed Current Deferred Revenue for 14 consecutive years, with $14.6 million as the latest value for Q4 2025.

  • Quarterly Current Deferred Revenue rose 10.31% to $14.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $14.6 million through Dec 2025, up 10.31% year-over-year, with the annual reading at $14.6 million for FY2025, 10.31% up from the prior year.
  • Current Deferred Revenue for Q4 2025 was $14.6 million at Repligen, down from $15.7 million in the prior quarter.
  • The five-year high for Current Deferred Revenue was $31.6 million in Q2 2023, with the low at $13.2 million in Q4 2024.
  • Average Current Deferred Revenue over 5 years is $19.7 million, with a median of $19.2 million recorded in 2022.
  • The sharpest move saw Current Deferred Revenue soared 54.95% in 2023, then crashed 55.64% in 2024.
  • Over 5 years, Current Deferred Revenue stood at $14.7 million in 2021, then surged by 31.4% to $19.3 million in 2022, then dropped by 11.49% to $17.1 million in 2023, then dropped by 22.41% to $13.2 million in 2024, then increased by 10.31% to $14.6 million in 2025.
  • According to Business Quant data, Current Deferred Revenue over the past three periods came in at $14.6 million, $15.7 million, and $20.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.